Clinical trial pipeline · Data from ClinicalTrials.gov
See which Her2 Positive Unresectable And Or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab And Taxane trials you may qualify forNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and/or meta…
The study is being conducted to evaluate whether the efficacy of SHR-A1811 is better than Pyrotinib in combination with Capecitabine in HER2-Positive, Unresecta…